Iron Deficiency Diagnosis and Assessment Techniques

Iron deficiency remains the most common micronutrient disorder worldwide, affecting populations from infants and pregnant women to the elderly and those with chronic disease. Traditional biochemical assays – notably serum ferritin, transferrin saturation and total iron-binding capacity – provide a snapshot of iron stores and circulating iron but are confounded by inflammation, infection and liver pathology. To overcome these limitations, modern haematology analysers report cellular indices such as reticulocyte haemoglobin content, hypochromic red blood cell percentages and red cell distribution width. These parameters detect iron-restricted erythropoiesis at an earlier stage than conventional tests, enabling rapid diagnosis and timely intervention. Novel algorithms integrating multiple indices further enhance discrimination between absolute and functional iron deficiency, and between iron deficiency and other microcytic anaemias. Point-of-care devices, imaging modalities and emerging biomarkers offer additional tools for community screening and specialised clinical settings. Together, these advances support a globally scalable, patient-centred approach to detecting, monitoring and managing iron deficiency across diverse healthcare environments.

Research from Nature Portfolio

A prospective study of iron-deficient sepsis patients demonstrated that divided doses of intravenous iron dextran rapidly normalise reticulocyte haemoglobin equivalent, with median time to Ret-He recovery of four days. Changes in reticulocyte subpopulations indicated a prompt surge in erythropoietic activity, underscoring the value of Ret-He as both a diagnostic marker and a therapeutic guide in critically ill cohorts.

Iron Deficiency Diagnosis and Assessment Techniques publication trend

The graph below shows the total number of articles in iron deficiency diagnosis and assessment techniques across all publications each year (not limited to Nature Index journals).

Technical terms

Reticulocyte haemoglobin equivalent (RET-He): the mean haemoglobin content of immature red cells, reflecting real-time iron incorporation.

Mean reticulocyte haemoglobin content (MCHr): an index of haemoglobin per reticulocyte, used to detect early iron-restricted erythropoiesis.

Ferritin: the intracellular iron storage protein measured in serum to estimate body iron reserves.

Transferrin saturation: the proportion of transferrin-bound iron, indicating circulating iron availability.

Hypochromic red blood cells: mature erythrocytes with reduced haemoglobin concentration, indicative of prolonged iron deficiency.

References

1. Iron deficiency in sepsis patients managed with divided doses of iron dextran: a prospective cohort study. Scientific Reports (2023).
2. Reticulocyte hemoglobin content associated with the risk of iron deficiency anemia. Heliyon (2024).
3. The validity of reticulocyte hemoglobin content and percentage of hypochromic red blood cells for screening iron-deficiency anemia among patients with end-stage renal disease: a retrospective analysis. BMC Nephrology (2020).
4. Reticulocyte and Erythrocyte Hemoglobin Parameters for Iron Deficiency and Anemia Diagnostics in Patient Blood Management. A Narrative Review. Journal of Clinical Medicine (2021).
5. Biomarkers of Hypochromia: The Contemporary Assessment of Iron Status and Erythropoiesis. BioMed Research International (2013).
6. Application of innovative hemocytometric parameters and algorithms for improvement of microcytic anemia discrimination. Hematology Reports (2015).